Exemed Pharmaceuticals to buy UCB Indian production facility
The deal, which is in line with UCB’s strategy on bringing new drugs to patients and less on mass manufacturing, includes a multi-year supply agreement between both the
WellSpan Health and Johns Hopkins Medicine have renewed their oncology collaboration, aiming to widen patient access to advanced care, clinical expertise, and research initiatives throughout central Pennsylvania, US.
Multi-centre, randomized trial designed to compare C3BS-CQR-1 treatment with sham treatment is expected to enroll at least 240 patients suffering from chronic advanced symptomatic heart failure. The composite
The efflux transporter knockout cell lines identify individual drug-transporter interactions, which is a component to understand the safety and efficacy characteristics of drug candidates. Sigma Life Science market